Nathan Hanflink, D.O.
Pain Medicine Physician in Eustis, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 951 in Pain Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Nathan Hanflink, D.O. reported a CMS MIPS final score of 74.7/100 - below the 83.1 national average - and filed 11,738 Medicare Part D claims in 2023.
- 74.7/100
- MIPS score · -8 vs avg
- 12K
- Part D claims, 2023
- 98%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Nathan Hanflink, D.O.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 12th percentile higher than 12% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Nathan Hanflink, D.O. sits
This provider among pain medicine physician peers
Across the 286 pain medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Nathan Hanflink, D.O. writes more Part D claims than 96% of them and scores higher on MIPS quality than 28% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pain medicine physician peer from a representative sample of 60; the gold marker is Nathan Hanflink, D.O.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Nathan Hanflink, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Nathan Hanflink, D.O.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Pain Medicine Physician compares to other specialties among Florida providers
Pain Medicine Physician ranks #211 among Florida's specialties (0% of in-state providers)
Each bar is a specialty's share of the Florida provider total, by primary NUCC taxonomy. The highlighted bar is Pain Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Nathan Hanflink, D.O.'s 2023 MIPS final score plotted against the Pain Medicine Physician national average
- MIPS Final Score
- 74.7/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pain Medicine Physician) - 74.7/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Pain Medicine Physician US NPIs
74.7/100 MIPS final score - 8.4 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pain Medicine Physician. Quality dim: 38.6.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Nathan Hanflink, D.O. appears in the CMS NPPES registry as a Pain Medicine Physician provider holding D.O. credentials at 601 JENNINGS AVE, Eustis, FL, 32726, with a listed phone of (352) 357-0668. NPI 1194778852 was issued on 05/17/2006.
Medicare Part D records for calendar year 2023 show 11,738 prescription claims written by this provider, covering 1,018 Medicare beneficiaries and totaling roughly $540K in drug spend, split 2% brand-name and 98% generic by claim count, with an opioid prescribing rate of 86.1%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.7/100 for the 2023 performance year (Quality 38.6), compared with the national average of 83.1.
Pain Medicine Physician is a narrow specialty nationwide, with 951 enrolled providers across 49 states and an average of 2,078 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1194778852 |
|---|---|
| Specialty | Pain Medicine Physician |
| Credentials | D.O. |
| Gender | Male |
| NPI Issued | 05/17/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Nathan Hanflink, D.O.'s current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1194778852 is the unique 10-digit identifier CMS uses to link Hanflink across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Nathan Hanflink, D.O.. To verify Nathan Hanflink, D.O.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
2% brand-name claims vs 98% generic, on 11,738 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 11,915
- Total Day Supply
- 352,661
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $93K
- Generic Drug Cost
- $447K
- Opioid Claims
- 10,111 (86.1% rate)
Patient Demographics
- Average Patient Age
- 67.1 years
- Avg HCC Risk Score
- 2.16
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 364, 65-74: 420, 75-84: 192, 85+: 42
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Nathan Hanflink, D.O. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
3,519 claims
- Oxycodone Hcl
Oxycodone Hcl
1,870 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
1,748 claims
- Morphine Sulfate Er 1,365
Morphine Sulfate Er
1,365 claims
- Tramadol Hcl 553
Tramadol Hcl
553 claims
- Gabapentin 468
Gabapentin
468 claims
- Cyclobenzaprine Hcl 295
Cyclobenzaprine Hcl
295 claims
- Fentanyl 278
Fentanyl
278 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,519 |
| Oxycodone Hcl | 1,870 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,748 |
| Morphine Sulfate Er Morphine Sulfate | 1,365 |
| Tramadol Hcl | 553 |
| Gabapentin | 468 |
| Cyclobenzaprine Hcl | 295 |
| Fentanyl | 278 |
| Tizanidine Hcl | 256 |
| Pregabalin | 204 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pain Medicine Physician Overview
How Nathan Hanflink, D.O. fits within the Pain Medicine Physician landscape nationally.
Nathan Hanflink, D.O.'s 11,738 claims are above the specialty average of 2,078.
Nearby Pain Medicine Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Hanflink.
Compare Pain Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Florida medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pain Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Florida
Frequently Asked Questions
What is Nathan Hanflink, D.O.'s specialty? ▼
How much does Nathan Hanflink, D.O. prescribe under Medicare Part D? ▼
What is Nathan Hanflink, D.O.'s Medicare quality score? ▼
Where is Nathan Hanflink, D.O. located? ▼
What is Nathan Hanflink, D.O.'s NPI number? ▼
Does Nathan Hanflink, D.O. prescribe more brand-name or generic drugs? ▼
Does Nathan Hanflink, D.O. prescribe opioids? ▼
How many Pain Medicine Physician providers are there in the US? ▼
What drugs does Nathan Hanflink, D.O. prescribe most often? ▼
Does Nathan Hanflink, D.O. accept Medicare? ▼
How can I verify Nathan Hanflink, D.O.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology